Atlas Trials

Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)

Clinical trial NCT00602823 · COMPLETED

Trial details

NCT number
NCT00602823
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Psoriasis
Start date
2006-02-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.